Tag Archives: MNK

Mallinckrodt (MNK) Gets a Hold Rating from Raymond James

Raymond James analyst Elliot Wilbur reiterated a Hold rating on Mallinckrodt (MNK – Research Report) yesterday. The company’s shares closed last Monday at $1.10, close to its 52-week low of $1.00. According to TipRanks.com, Wilbur has currently 0 stars on

Analysts Conflicted on These Healthcare Names: Mallinckrodt (NYSE: MNK), BioMarin Pharmaceutical (NASDAQ: BMRN) and Cocrystal Pharma (NASDAQ: COCP)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mallinckrodt (MNK – Research Report), BioMarin Pharmaceutical (BMRN – Research Report) and Cocrystal Pharma (COCP – Research Report). Mallinckrodt (MNK) In a report released yesterday,

Mallinckrodt (MNK) Gets a Sell Rating from Merrill Lynch

In a report released today, Jason Gerberry from Merrill Lynch maintained a Sell rating on Mallinckrodt (MNK – Research Report), with a price target of $3.00. The company’s shares closed last Monday at $4.18, close to its 52-week low of

Friday’s Highlights at Noon: Mallinckrodt (MNK), Peabody Energy Comm (BTU), Rite Aid (RAD), Glu Mobile (GLUU), Brainstorm Cell Therapeutics (BCLI)

So far Friday, February 21, NASDAQ is down -1.87% and the S&P is down -1.22%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Mallinckrodt (MNK – Research Report), Peabody Energy Comm (BTU –

Tuesday’s Midday Movers: Navios Maritime Partners (NMM), Mallinckrodt (MNK), Ambarella (AMBA), Ballard Power Systems (BLDP), LendingClub (LC)

So far Tuesday, February 11, NASDAQ is down -0.87% and the S&P is down -0.01%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Navios Maritime Partners (NMM – Research Report), Mallinckrodt (MNK –

Saturday’s Highlights at Noon: Exelixis (EXEL), Mallinckrodt (MNK), Stratasys (SSYS), Sangamo Biosciences (SGMO), Karyopharm Therapeutics (KPTI)

So far Saturday, January 25, NASDAQ is down -5.75% and the S&P is down -3.67%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Exelixis (EXEL – Research Report), Mallinckrodt (MNK – Research Report),